Health tech deals
McDermott Will & Schulte has advised Maire Group on the conclusion and implementation of its joint venture agreements with Newcleo SA. Maire, through its subsidiary Nextchem, and Newcleo SA, an innovative company in the nuclear energy sector co‑founded by Stefano Buono, have completed the establishment of NEXT‑N, a joint venture focused on developing advanced technologies [...]
McDermott Will & Schulte has advised Groupe Bruxelles Lambert (“GBL”) in connection with its strategic investment in Rayner, a leading ophthalmic MedTech specialist. GBL has signed definitive agreements to acquire a 45% co‑control stake in Rayner. Under the transaction, GBL will invest €0.5 billion of equity alongside incumbent shareholders, including CVC and the Rayner management [...]
LUMO Labs’ LUMO Fund has secured €6m from Spain’s state-backed investment arm SETT to support early-stage startups across Spain and Europe. The €100m LUMO Fund is a multi-stage venture capital fund covering pre-seed to Series A investments. It plans to invest in around 30 to 35 startups over the next four years. The fund also [...]
Ease Health has launched with US$41m in early-stage funding to expand adoption of its behavioural health software platform among large providers treating mental health and substance use conditions. The New York-based startup has developed a platform that combines admissions processing, patient management and billing tools for behavioural health providers. Many providers rely on two separate [...]
Generate:Biomedicines has raised US$400m in the year’s biggest biotech IPO so far, with proceeds earmarked for clinical trials and R&D on its artificial intelligence platform. The drug developer, which focuses on immunology and inflammation as well as oncology, priced shares at US$16 and began trading on the Nasdaq Global Market under the symbol GENB. [...]
Esperion Therapeutics has agreed to acquire Corstasis Therapeutics in a deal worth up to US$255m, adding a nasal spray treatment for heart failure-related fluid retention to its portfolio. Under the agreement, Esperion will pay US$75m in upfront cash for all outstanding Corstasis shares. Shareholders may also receive up to US$180m in additional payments linked to [...]
McDermott Will & Schulte advised Fidia Farmaceutici S.p.A. on its acquisition of Altacor Ltd, a UK‑based ophthalmic products company. The transaction marks a significant strategic step for Fidia as it enters the UK ophthalmology market directly, enhancing its presence in one of the group’s core therapeutic areas. Through the acquisition, Fidia expands its portfolio with [...]
YOU(th) has closed a US$4.5m funding round to expand its smartphone health screening platform, which uses AI and machine learning to assess health risks in under two minutes. The digital health company, which aims to expand preventive care globally, said rising interest in longevity among younger people alongside an ageing population is increasing demand for [...]
Brainomix has expanded its Series C round to £18.8m to scale its AI stroke and lung imaging platforms, with a focus on accelerating deployment in the US. The company added £4.8m to fund growth of its two core products. Brainomix 360 Stroke automates imaging assessment across the acute stroke pathway to support treatment and patient [...]
AI neuro platform nyra health has raised €20m in a Series A round to expand its AI-based neurological therapy services in Europe and the US. The Vienna-based company said the funding will be used to expand its technology platform in the DACH region, accelerate growth in the US and pursue its aim of setting a [...]
